Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints
暂无分享,去创建一个
J. Kulisevsky | P. Martínez-Martín | P. Pástor | M. Kurtis | M. Aguilar | S. Jesús | P. Mir | E. Cubo | D. Santos-García | C. Valero | N. Caballol | J. Hernández Vara | L. López Manzanares | J. C. Martínez Castrillo | D. McAfee | J. García Caldentey | L. Planellas | I. Cabo | M. A. Ávila Rivera | M. G. Alonso Losada | M. Álvarez Sauco | M. Blázquez Estrada | C. Borrué | F. Carrillo Padilla | S. Escalante | I. Gastón | I. González Aramburu | J. González Ardura | I. Legarda | N. López Ariztegui | V. Nogueira | C. Ordás | V. Puente | J. Rúiz Martínez | M. Seijo | L. Vela | O. de Fábregues | J. M. Paz González | C. Cores Bartolomé | T. de Deus Fonticoba | M. Cosgaya | D. Santos‐García | J. Dotor García-Soto | Cristina Martínez Miró | Víctor Gómez Mayordomo | B. Solano Vila | Ruben Alonso Redondo | M. F. Feal Painceiras | P. Sánchez Alonso | Luis M López Díaz L
[1] Jiu Chen,et al. Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment , 2021, Frontiers in Neuroscience.
[2] D. Aarsland,et al. Parkinson disease-associated cognitive impairment , 2021, Nature Reviews Disease Primers.
[3] H. Berendse,et al. Visual hallucinations in Parkinson’s disease are associated with thinning of the inner retina , 2020, Scientific Reports.
[4] Y. Iguchi,et al. Risk factors for minor hallucinations in Parkinson's disease , 2020, Acta neurologica Scandinavica.
[5] Zheyu Xu,et al. Subjective cognitive Complaints in early Parkinson's disease patients with normal cognition are associated with affective symptoms. , 2020, Parkinsonism & related disorders.
[6] J. Kulisevsky,et al. Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson's disease , 2020, European journal of neurology.
[7] D. Collerton,et al. Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia , 2020, Frontiers in Neurology.
[8] J. Trojanowski,et al. Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine? , 2020, Movement disorders : official journal of the Movement Disorder Society.
[9] I. Parees,et al. The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype , 2020, Neurological Sciences.
[10] B. Mollenhauer,et al. Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide , 2020, Movement disorders clinical practice.
[11] J. Kulisevsky,et al. Non‐motor symptom burden is strongly correlated to motor complications in patients with Parkinson’s disease , 2020, European journal of neurology.
[12] Jianpin Liu,et al. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson’s disease: a Chinese population-based study , 2019, Neurological Sciences.
[13] I. Parees,et al. COPPADIS‐2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation , 2019, European journal of neurology.
[14] P. Bugalho,et al. Cognitive complaints in Parkinson’s disease patients: from subjective cognitive complaints to dementia and affective disorders , 2019, Journal of Neural Transmission.
[15] A. Nieto,et al. Subjective cognitive decline and progression to dementia in Parkinson’s disease: a long-term follow-up study , 2019, Journal of Neurology.
[16] R. Kliegl,et al. How to capitalize on a priori contrasts in linear (mixed) models: A tutorial , 2018, Journal of Memory and Language.
[17] Marios Politis,et al. Cognitive decline in Parkinson disease , 2017, Nature Reviews Neurology.
[18] Yang Pan,et al. Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease , 2017, Journal of the Neurological Sciences.
[19] J. Kulisevsky,et al. COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression , 2016, BMC Neurology.
[20] D. Chan,et al. Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson’s Disease Patients , 2015, Front. Neurol..
[21] D. Moser,et al. Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patients , 2014, European journal of neurology.
[22] Y. Sohn,et al. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease , 2014, Neurobiology of Aging.
[23] M. T. Pellecchia,et al. Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? , 2014, Journal of geriatric psychiatry and neurology.
[24] J. Kulisevsky,et al. Parkinson's disease‐cognitive rating scale: Psychometrics for mild cognitive impairment , 2013, Movement disorders : official journal of the Movement Disorder Society.
[25] N. Bargalló,et al. Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study. , 2013, Parkinsonism & related disorders.
[26] S. Landau,et al. Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4‐year study , 2013, International journal of geriatric psychiatry.
[27] J. Kulisevsky,et al. Cognitive impairment and dementia in Parkinson's disease , 2012, Neurobiology of Disease.
[28] K. Chaudhuri,et al. The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[29] D. Aarsland,et al. The epidemiology of dementia associated with Parkinson disease , 2010, Journal of the Neurological Sciences.
[30] Thomas Foltynie,et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.
[31] I. McKeith,et al. A semi‐structured interview to assess visual hallucinations in older people , 2008, International journal of geriatric psychiatry.
[32] Jaime Kulisevsky,et al. Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[33] E. Tolosa,et al. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.
[34] Paolo Barone,et al. The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study , 2007, Movement disorders : official journal of the Movement Disorder Society.
[35] B. Laurent,et al. The cognitive complaint interview (CCI) , 2006 .
[36] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[37] A. David,et al. Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.
[38] J. Sanchez-Ramos,et al. Visual hallucinations associated with Parkinson disease. , 1996, Archives of neurology.
[39] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.